Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,231 | -68,375 | -83,479 | -53,552 | -19,770 |
| Depreciation Amortization | 1,677 | 3,219 | 2,343 | 1,079 | 1,096 |
| Accounts receivable | -23,261 | -52 | 6,606 | -13,441 | 66 |
| Other Working Capital | -29,497 | 106 | 22,103 | -20,171 | -21,195 |
| Other Operating Activity | 46,229 | 17,584 | 3,088 | 21,806 | 5,503 |
| Operating Cash Flow | $-37,083 | $-47,518 | $-49,339 | $-64,279 | $-34,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,248 | -31,583 | -45,572 | N/A | N/A |
| PPE Investments | -2,360 | -1,368 | -2,297 | -1,413 | -829 |
| Investing Cash Flow | $5,888 | $-32,951 | $-47,869 | $-1,413 | $-829 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 29,661 | N/A |
| Debt Issued | 0 | 0 | 19,985 | N/A | N/A |
| Common Stock Issued | 13,098 | 114,501 | 5,079 | 83,157 | 4,749 |
| Financing Cash Flow | $13,098 | $114,501 | $25,064 | $112,818 | $4,749 |
| Beginning Cash Position | 61,889 | 27,357 | 99,501 | 52,375 | 82,756 |
| End Cash Position | 43,792 | 61,389 | 27,357 | 99,501 | 52,376 |
| Net Cash Flow | $-18,097 | $34,032 | $-72,144 | $47,126 | $-30,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,083 | -47,518 | -49,339 | -64,279 | -34,300 |
| Capital Expenditure | -2,360 | -1,368 | -2,297 | -1,413 | -829 |
| Free Cash Flow | -39,443 | -48,886 | -51,636 | -65,692 | -35,129 |